Published on November 30, 2009 at 7:13 AM
Research and Markets (http://www.researchandmarkets.com/research/2a2b03/boston_scientific) has announced the addition of the "Boston Scientific Medical Device Company Intelligence Report" company profile to their offering.
Boston Scientific develops and manufactures medical devices that are used in a range of interventional medical specialties, including interventional cardiology, cardiac rhythm management (CRM), peripheral interventions, electrophysiology, neurovascular intervention, endoscopy, urology, gynaecology and neuromodulation.
The company's history began in the late-1960s when its co-founder, John Abele, acquired an equity interest in Medi-tech Inc, a research and development company focused on developing alternatives to surgery. Medi-tech introduced its initial products in 1969 - a range of steerable catheters used in some of the first less-invasive procedures performed. In 1979, John Abele joined with Pete Nicholas to form Boston Scientific, which indirectly acquired Medi-tech. This acquisition began a period of new product development and organisational growth. Since then, the company's net sales have increased substantially, growing from US$2 million in 1979 to approximately US$8.1 billion in 2008.
Source: Espicom Business Intelligence Ltd